Company

Quidel Corporation

Headquarters: San Diego, CA, United States

Founded: 1979

Employees: 1,600

CEO: Mr. Douglas C. Bryant

NASDAQ: QDEL +0.36%

Market Cap

$4.86 Billion

USD as of Jan. 1, 2024

Market Cap History

Quidel Corporation market capitalization over time

Evolution of Quidel Corporation market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Quidel Corporation

Detailed Description

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; Savanna, an automated in vitro molecular diagnostic platform; and Virena, a wireless cellular data management and surveillance system. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Quidel Corporation has the following listings and related stock indices.


Stock: NASDAQ: QDEL wb_incandescent

Stock: BMV: QDEL wb_incandescent

Stock: FSX: QL1 wb_incandescent

Product & Services

Diagnostic healthcare manufacturer

Key People

Founder(s): Dr. David H. Katz, M. D.

Douglas C. Bryant, President & CEO Randall J. Steward, CFO

Financials

Revenue: $534.2 Million(2019)

Details

Headquarters:

9975 Summers Ridge Road

San Diego, CA 92121

United States

Phone: 858 552 1100

Fax: 858 453 4338